在接受rt-PA治疗的急性缺血性卒中患者中，凝血酶原时间快速百分比值下降与有症状和无症状颅内出血均相关。 - Suppr | 超能文献

Drop of PT Quick percent value is associated with both symptomatic and asymptomatic intracranial hemorrhage in patients treated with rt-PA for acute ischemic stroke.

作者信息

Alonso A, Dempfle C E, Szabo K, Zohsel K, Hennerici M G

出版信息

Thromb Res. 2011 Jan;127(1):65-6. doi: 10.1016/j.thromres.2010.04.018.

DOI:10.1016/j.thromres.2010.04.018

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Drop of PT Quick percent value is associated with both symptomatic and asymptomatic intracranial hemorrhage in patients treated with rt-PA for acute ischemic stroke.在接受rt-PA治疗的急性缺血性卒中患者中，凝血酶原时间快速百分比值下降与有症状和无症状颅内出血均相关。

Thromb Res. 2011 Jan;127(1):65-6. doi: 10.1016/j.thromres.2010.04.018.

2

Risk of thrombolytic therapy for acute ischemic stroke in patients with current malignancy.当前恶性肿瘤患者急性缺血性脑卒中溶栓治疗的风险。

J Stroke Cerebrovasc Dis. 2011 Mar-Apr;20(2):124-30. doi: 10.1016/j.jstrokecerebrovasdis.2009.10.010. Epub 2010 Jul 3.

3

Thrombolysis at 3-4.5 hours after acute ischemic stroke onset--evidence from the Canadian Alteplase for Stroke Effectiveness Study (CASES) registry.急性缺血性脑卒中发病后 3-4.5 小时的溶栓治疗-来自加拿大阿替普酶治疗脑卒中有效性研究（CASES）登记研究的证据。

Cerebrovasc Dis. 2011;31(3):223-8. doi: 10.1159/000321893. Epub 2010 Dec 21.

4

Treating as early as possible with thrombolysis is crucial, but can we do better in the sub-4.5-hour time window?尽早进行溶栓治疗至关重要，但在4.5小时以内的时间窗内我们能否做得更好呢？

Cerebrovasc Dis. 2011;31(3):229. doi: 10.1159/000322555. Epub 2010 Dec 21.

5

Post-thrombolytic hyperglycemia and 3-month outcome in acute ischemic stroke.溶栓后高血糖与急性缺血性脑卒中 3 个月结局。

Cerebrovasc Dis. 2011;31(1):83-92. doi: 10.1159/000321332. Epub 2010 Nov 16.

6

Older age does not increase risk of hemorrhagic complications after intravenous and/or intra-arterial thrombolysis for acute stroke.年龄较大并不会增加急性卒中静脉和/或动脉内溶栓后出血并发症的风险。

J Stroke Cerebrovasc Dis. 2008 Sep;17(5):266-72. doi: 10.1016/j.jstrokecerebrovasdis.2008.03.003.

7

Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke.急性缺血性卒中中联合静脉和动脉溶栓与使用重组组织型纤溶酶原激活剂进行原发性动脉治疗的比较。

J Stroke Cerebrovasc Dis. 2008 May-Jun;17(3):121-8. doi: 10.1016/j.jstrokecerebrovasdis.2007.12.004.

8

A model to prevent fibrinolysis in patients with stroke mimics.卒中样发作患者纤维蛋白溶解预防模型。

J Stroke Cerebrovasc Dis. 2012 Nov;21(8):839-43. doi: 10.1016/j.jstrokecerebrovasdis.2011.04.018. Epub 2011 Jun 2.

9

Predictors of in-hospital mortality and the risk of symptomatic intracerebral hemorrhage after thrombolytic therapy with recombinant tissue plasminogen activator in acute ischemic stroke.重组组织型纤溶酶原激活剂溶栓治疗急性缺血性脑卒中后院内死亡率及症状性颅内出血的风险预测因素。

J Stroke Cerebrovasc Dis. 2014 Jan;23(1):7-11. doi: 10.1016/j.jstrokecerebrovasdis.2012.04.004. Epub 2012 May 11.

10

Antiplatelet therapy in combination with rt-PA thrombolysis in ischemic stroke (ARTIS): rationale and design of a randomized controlled trial.抗血小板治疗联合 rt-PA 溶栓治疗缺血性脑卒中（ARTIS）：一项随机对照试验的原理和设计。

Cerebrovasc Dis. 2010;29(1):79-81. doi: 10.1159/000256651. Epub 2009 Nov 10.

引用本文的文献

1

Fibrinogen Concentrate for the Treatment of Thrombolysis-Associated Hemorrhage in Adult Ischemic Stroke Patients.纤维蛋白原浓缩物治疗成人缺血性脑卒中溶栓相关出血。

Clin Appl Thromb Hemost. 2020 Jan-Dec;26:1076029620951867. doi: 10.1177/1076029620951867.